These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25447302)

  • 1. Positive reinforcing effect of neurotensin microinjection into the ventral pallidum in conditioned place preference test.
    Ollmann T; Péczely L; László K; Kovács A; Gálosi R; Berente E; Karádi Z; Lénárd L
    Behav Brain Res; 2015 Feb; 278():470-5. PubMed ID: 25447302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic effect of neurotensin microinjection into the ventral pallidum.
    Ollmann T; Péczely L; László K; Kovács A; Gálosi R; Kertes E; Kállai V; Zagorácz O; Karádi Z; Lénárd L
    Behav Brain Res; 2015 Nov; 294():208-14. PubMed ID: 26296669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of neurotensin in positive reinforcement in the rat central nucleus of amygdala.
    László K; Tóth K; Kertes E; Péczely L; Lénárd L
    Behav Brain Res; 2010 Apr; 208(2):430-5. PubMed ID: 20035801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neurotensin in passive avoidance learning in the rat central nucleus of amygdala.
    László K; Tóth K; Kertes E; Péczely L; Ollmann T; Madarassy-Szücs A; Lénárd L
    Behav Brain Res; 2012 Jan; 226(2):597-600. PubMed ID: 21946307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of intraamygdaloid neurotensin and dopamine interaction in conditioned place preference.
    László K; Péczely L; Kovács A; Zagoracz O; Ollmann T; Kertes E; Kállai V; Csetényi B; Karádi Z; Lénárd L
    Behav Brain Res; 2018 May; 344():85-90. PubMed ID: 29462652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neurotensin in amygdaloid spatial learning mechanisms.
    László K; Tóth K; Kertes E; Péczely L; Ollmann T; Lénárd L
    Behav Brain Res; 2010 Jul; 210(2):280-3. PubMed ID: 20219557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of D1 dopamine receptors of the ventral pallidum in inhibitory avoidance learning.
    Péczely L; Ollmann T; László K; Kovács A; Gálosi R; Szabó Á; Karádi Z; Lénárd L
    Behav Brain Res; 2014 Aug; 270():131-6. PubMed ID: 24815313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of reversible inactivation of the ventral tegmental area on the acquisition and expression of morphine-induced conditioned place preference in the rat.
    Moaddab M; Haghparast A; Hassanpour-Ezatti M
    Behav Brain Res; 2009 Mar; 198(2):466-71. PubMed ID: 19073220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of neurotensin microinjected into ventral tegmental area on spontaneous motor activity in neonatal 6-hydroxydopamine-treated rats].
    Ikegami M; Iwasaki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):83-5. PubMed ID: 15164616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
    Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin in the ventral pallidum increases extracellular gamma-aminobutyric acid and differentially affects cue- and cocaine-primed reinstatement.
    Torregrossa MM; Kalivas PW
    J Pharmacol Exp Ther; 2008 May; 325(2):556-66. PubMed ID: 18252810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive reinforcing effects of RFamide-related peptide-1 in the rat central nucleus of amygdala.
    Lénárd L; Kovács A; Ollmann T; Péczely L; Zagoracz O; Gálosi R; László K
    Behav Brain Res; 2014 Dec; 275():101-6. PubMed ID: 25193319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediation by neurotensin-receptors of effects of neurotensin on self-stimulation of the medial prefrontal cortex.
    Fernández R; Sabater R; Sáez JA; Montes R; Alba F; Ferrer JM
    Br J Pharmacol; 1996 Sep; 119(2):299-302. PubMed ID: 8886412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
    Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
    Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of D1- and D2-like Dopamine Receptor Antagonists on the Rewarding and Anxiolytic Effects of Neurotensin in the Ventral Pallidum.
    Ollmann T; Lénárd L; Péczely L; Berta B; Kertes E; Zagorácz O; Hormay E; László K; Szabó Á; Gálosi R; Karádi Z; Kállai V
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin antagonist acutely and robustly attenuates locomotion that accompanies stimulation of a neurotensin-containing pathway from rostrobasal forebrain to the ventral tegmental area.
    Reynolds SM; Geisler S; Bérod A; Zahm DS
    Eur J Neurosci; 2006 Jul; 24(1):188-96. PubMed ID: 16882016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.
    Croci T; Landi M; Gully D; Maffrand JP; Le Fur G; Manara L
    Br J Pharmacol; 1997 Apr; 120(7):1312-8. PubMed ID: 9105707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent pain-facilitatory and -inhibitory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: influence on the antinociceptive effect of morphine.
    Smith DJ; Hawranko AA; Monroe PJ; Gully D; Urban MO; Craig CR; Smith JP; Smith DL
    J Pharmacol Exp Ther; 1997 Aug; 282(2):899-908. PubMed ID: 9262357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neurotensin analog blocks cocaine-conditioned place preference and reinstatement.
    Boules M; Netz R; Fredrickson PA; Richelson E
    Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):236-9. PubMed ID: 26901162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference.
    Felszeghy K; Espinosa JM; Scarna H; Bérod A; Rostène W; Pélaprat D
    Neuropsychopharmacology; 2007 Dec; 32(12):2601-10. PubMed ID: 17356568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.